Development of a sensitive LC-MS/MS assay to support human microdose study for an oral agonist of the GLP-1 receptor-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development of a sensitive LC-MS/MS assay to support human microdose study for an oral agonist of the GLP-1 receptor

Published:2024-06-02 Issue:11 Volume:16 Page:545-555
ISSN:1757-6180
Container-title:Bioanalysis
language:en
Short-container-title:Bioanalysis

Author:

Kadar Eugene P¹^ORCID,Eng Heather¹^ORCID,Kalgutkar Amit S²^ORCID,Holliman Christopher L¹,Steeno Gregory S³

Affiliation:

1. Medicine Design, Pfizer Worldwide Research & Development, Pfizer Inc., Groton, CT 06430, USA

2. Medicine Design, Pfizer Worldwide Research & Development, Pfizer Inc., Cambridge, MA 02139, USA

3. Global Biometrics and Data Management, Pfizer Worldwide Research & Development, Pfizer Inc., Groton, CT 06430, USA

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/17576180.2024.2349421

Reference18 articles.

1. Phase 0/microdosing approaches: time for mainstream application in drug development?

2. Microdosing and drug development: past, present and future

3. Microdosing as a Potential Tool to Enhance Clinical Development of Novel Antibiotics: A Tissue and Plasma PK Feasibility Study with Ciprofloxacin

4. Analytical validation of accelerator mass spectrometry for pharmaceutical development

5. Applications of accelerator mass spectrometry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP